Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 170 shares of common stock to cover tax withholding obligations arising from the vesting of restricted share units on March 26, 2024.
Summary
- On March 26, 2024, Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, disposed of 170 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted share units.
- The price per share was $128.11.
- Following the transaction, Delaney directly owns 5,433 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't convey any particularly positive or negative sentiment about the company's performance or future prospects.
Industry Context
Form 4 filings are a routine part of insider trading activity and are closely monitored by investors for signals about a company's prospects. This particular transaction appears to be a standard sale to cover tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Date of transaction: Disposition of 170 shares of common stock to cover tax withholding obligations. |
| 03/28/2024 | Date of signature by Sean D. Mersten, Attorney in Fact for Mark E. Delaney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.